Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (71-80 of 197) with videos related to

Pageof 20
Sort By:
Acta Neuropathologica|March 24, 2026
Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2<sup>308/Y</sup> transgenic model of Rett syndromeEdith Doppler, Edward Rockenstein, Kiren Ubhi, et al.
Plos One|February 10, 2011
Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's diseaseBrian Spencer, Robert A Marr, Ryan Gindi, et al.
Plos One|February 23, 2010
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyLeslie Crews, Brian Spencer, Paula Desplats, et al.
Experimental Neurology|January 28, 2012
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathyKiren Ubhi, Chandra Inglis, Michael Mante, et al.
Experimental Neurology|June 27, 2024
Corrigendum to "Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy" Exp Neurol. 2012 April; 234(2): 405-416Kiren Ubhi, Chandra Inglis, Michael Mante, et al.
Plos One|August 20, 2025
Correction: Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's DiseaseBrian Spencer, Robert A Marr, Ryan Gindi, et al.
Journal of Alzheimer'S Disease : JAD|November 9, 2011
Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibodyMarkus Mandler, Edward Rockenstein, Kiren Ubhi, et al.
Nature Neuroscience|September 2, 2005
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic modelOded Singer, Robert A Marr, Edward Rockenstein, et al.
The European Journal of Neuroscience|December 6, 2013
Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96Kiren Ubhi, Edward Rockenstein, Christine Kragh, et al.
Acta Neuropathologica|July 5, 2008
Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndromeEdith Doppler, Edward Rockenstein, Kiren Ubhi, et al.
Pageof 20

Showing results (71-80 of 197) with videos related to

Sort By:
Pageof 20
Acta Neuropathologica|March 24, 2026
Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2<sup>308/Y</sup> transgenic model of Rett syndromeEdith Doppler, Edward Rockenstein, Kiren Ubhi, et al.
Plos One|February 10, 2011
Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's diseaseBrian Spencer, Robert A Marr, Ryan Gindi, et al.
Plos One|February 23, 2010
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyLeslie Crews, Brian Spencer, Paula Desplats, et al.
Experimental Neurology|January 28, 2012
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathyKiren Ubhi, Chandra Inglis, Michael Mante, et al.
Experimental Neurology|June 27, 2024
Corrigendum to "Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy" Exp Neurol. 2012 April; 234(2): 405-416Kiren Ubhi, Chandra Inglis, Michael Mante, et al.
Plos One|August 20, 2025
Correction: Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's DiseaseBrian Spencer, Robert A Marr, Ryan Gindi, et al.
Journal of Alzheimer'S Disease : JAD|November 9, 2011
Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibodyMarkus Mandler, Edward Rockenstein, Kiren Ubhi, et al.
Nature Neuroscience|September 2, 2005
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic modelOded Singer, Robert A Marr, Edward Rockenstein, et al.
The European Journal of Neuroscience|December 6, 2013
Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96Kiren Ubhi, Edward Rockenstein, Christine Kragh, et al.
Acta Neuropathologica|July 5, 2008
Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndromeEdith Doppler, Edward Rockenstein, Kiren Ubhi, et al.
Pageof 20